Affimed N.V Net debt/EBITDA
Что обозначает Net debt/EBITDA в Affimed N.V?
Net debt/EBITDA Affimed N.V. является 10.32
Какое определение для Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA компаний в Health Care сектор на NASDAQ по сравнению с Affimed N.V
Что делает Affimed N.V?
affimed (symbol: afmd) is a nasdaq-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. immuno-oncology represents a highly promising approach to cancer treatment that seeks to harness the body’s own immune defenses to attack and destroy tumor cells. natural killer cells, or nk-cells, and t-cells belong to the most potent cells of the human defense arsenal. affimed’s proprietary, next-generation bispecific antibodies, termed tandabs®, are designed to bring nk-cells or t-cells into close proximity to cancer cells that ultimately triggers a signal cascade that leads to the destruction of cancer cells. due to their novel tetravalent tandem architecture, which provides for four binding domains, the tandabs bind to specific targets on immune and cancer cells with high affinity. in addition, tandabs exhibit kinetic properties allowing the administration as regular intravenous infusion and fine-tuning of dosing. affimed beli
Компании с net debt/ebitda похож на Affimed N.V
- Magyar Bancorp имеет Net debt/EBITDA из 10.29
- Imperial Brands Plc имеет Net debt/EBITDA из 10.29
- China Oil And Gas имеет Net debt/EBITDA из 10.30
- Stanley Black & Decker имеет Net debt/EBITDA из 10.30
- The Clorox имеет Net debt/EBITDA из 10.32
- The Clorox имеет Net debt/EBITDA из 10.32
- Affimed N.V имеет Net debt/EBITDA из 10.32
- Lok'nStore Plc имеет Net debt/EBITDA из 10.32
- Independent Bank имеет Net debt/EBITDA из 10.33
- United Security Bancshares (CA) имеет Net debt/EBITDA из 10.34
- Weyerhaeuser Co имеет Net debt/EBITDA из 10.34
- Union Pacific имеет Net debt/EBITDA из 10.34
- Judges Scientific Plc имеет Net debt/EBITDA из 10.36